Xperienc and medical cannabis
What is Xperienc Global Labs?
A London company (Companies House 17030182) for biotech R&D, founded by Bairo Gonzalez, bringing together digital health and medical cannabis.
Xperienc Global Labs Ltd is a company registered in London, at Companies House, under number 17030182, with experimental research and development in biotechnology as its activity. It was incorporated on February 12, 2026 by Bairo Leandro Gonzalez Martinez, who is its Director. Its focus is to bring together digital health and research in medical cannabis.
What Xperienc develops
- Laboratory platform: connects laboratories to requests and orders, much like an on-demand services app.
- Teleconsultation with a clinical assistant: AI organizes information and keeps track of the history; the one who assesses and decides is always a health professional.
- Self-service booths integrated with the clinical assistant.
- Research in medical cannabis, with graded evidence and no promise of results.
A second opinion, not a medical report
One of the pieces is Global Language, an instant translator that lets patient and specialist each speak their own language. That way, a professional in another country can study the case and offer a clinical second opinion to the colleague treating the patient. It counts as an opinion, not as a medical report: it replaces neither the consultation, nor the exam, nor the person in charge of treatment.
The proposal is for records to stay in the patient's private dashboard. In the ecosystem, Xperienc is what Bairo calls the neural connection layer: the part that links people, professionals and laboratories. Hospital Granja Julieta, in São Paulo, is Xperienc's clinical partner and a company separate from it.